Aptorum Group Limited: Aptorum Group Announces Completion of

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions

Related Keywords

United States , Canada , Singapore , Dennis Riedl , Clark Cheng , Craig Brelsford , Ghislaine Gasparetto , Aptorum Group Form , Aptorum Group Or , Drug Administration , Singapore Agency For Science , Actifin Financial Communications Europe , Redchip Financial Communications United States , Daptorum Group , Aptorum Group Limited Nasdaq , Regulatory News , Group Limited , Euronext Paris , Methicillin Resistant Staphylococcus Aureus , Acute Bacterial Skin , Skin Structure Infections , Chief Medical Officer , Executive Director , Serious Adverse Events , Aptorum Group Limited , Securities Litigation Reform Act , French Autorit , Des March , Regulations Delegated , Financial Communications United States , Financial Communications Europe , Aptorum , Group , Imited , Nnounces , Completion , Discussions , First , Glass , Mall , Olecule , Drug , Targeting , Methicillin , Resistant , Staphylococcus , Laureus ,